BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Deng XR, Zhai YJ, Shi XY, Tang SS, Fang YY, Heng HY, Zhao LY, Yuan HJ. Characteristic dysbiosis in patients with type 2 diabetes and hyperuricemia, and the effect of empagliflozin on gut microbiota. World J Diabetes 2025; 16(4): 102970 [PMID: 40236847 DOI: 10.4239/wjd.v16.i4.102970]
URL: https://www.wjgnet.com/1948-9358/full/v16/i4/102970.htm
(98) (101) (0) (0) (2990) (1)
Number Citing Articles
1
Ying Chang, Yuanjiang Zhou, Fanlin Zhou, Jie Liang, Gangyi Yang, Peng Zhang, Mingyuan Tian. Empagliflozin improves gut microbial disturbances and intestinal barrier integrity in STZ-induced type 2 diabetic mice. Journal of Endocrinology 2026; 270(3) doi: 10.1530/JOE-26-0110
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.